Ernest N. Morial Convention Center
Great Hall B & C, First Floor
901 Convention Center Blvd.
New Orleans, LA 70130
4:15 PM: Registration and Refreshments
4:45 PM: Welcome, Introduction, and Polling (Edward J. Fox, MD, PhD)
5:00 PM: Engaging Patients in Care at Disease Onset: Shared Decision-Making Science and Stories #1 (Edward J. Fox, MD, PhD)
5:20 PM: Maintaining a Therapeutic Alliance in Highly Active/Worsening MS: Shared Decision-Making Science and Stories #2 (Stephen Krieger, MD, FAAN)
5:40 PM: Managing Expectations and Allaying Fears About Potential Adverse Effects and Safety Monitoring: Shared Decision-Making Science and Stories #3 (Lori Mayer, DNP, MSN, RN, MSCN)
6:00 PM: Q&A and Concluding Remarks (Panel)
In conjunction with the 2017 Annual Meeting of the CMSC, this live educational symposium is designed to improve your knowledge and skill in the management of individuals with relapsing-remitting multiple sclerosis. In this activity, experts will combine key clinical concepts and data on approved disease-modifying therapies with personal stories of patients in their care to illuminate how they’ve empowered these individuals to actively participate in treatment decisions throughout the course of their disease.
Upon completion of this activity, participants will be able to:
This activity has been designed to meet the educational needs of neurologists, NPs, PAs, pharmacists, nurses, and other clinicians involved in the management of patients with multiple sclerosis.
The purpose of this activity is to improve knowledge and competence of nurses concerning the treatment of multiple sclerosis.
In order to receive credit, participants must attend the live activity and complete the evaluation and request for credit. There are no prerequisites and there is no fee to participate in this activity or to receive CME/CE/CPE credit. Statements of Credit are awarded upon completion of the evaluation and request for credit at the end of the post-test and evaluation form.
For pharmacists, Medical Learning Institute, Inc. will accept your completed evaluation form up to 30 days following participation and will report your participation in this educational activity to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks of participation, you will receive a confirmation email and can then view your participation record at the NABP website: mycpemonitor.net.
Release and Expiration Date: May 24, 2017
Time to Complete: 90 minutes
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE/CPE activity for any amount during the past 12 months.
Edward J. Fox, MD, PhD
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas
Stephen Krieger, MD, FAAN
Associate Professor of Neurology
Director, Neurology Residency Program
Corinne Goldsmith Dickinson Center for MS
Mount Sinai Medical Center
New York, New York
Lori Mayer, DNP, MSN, RN, MSCN
Director of Medical Research Services,
MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas
Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education
The information provided at this CME/CE/CPE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hour(s).
The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this application-based activity provides for 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit. The Universal Activity Number for this activity is 0468-9999-17-002-L01-P.
This CME/CE/CPE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from Sanofi Genzyme.
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.